ATE551067T1 - Tumstatin zur behandlung von erkrankungen die mit der neumodellierung von atemwegsgewebe zusammenhängen - Google Patents

Tumstatin zur behandlung von erkrankungen die mit der neumodellierung von atemwegsgewebe zusammenhängen

Info

Publication number
ATE551067T1
ATE551067T1 AT07710533T AT07710533T ATE551067T1 AT E551067 T1 ATE551067 T1 AT E551067T1 AT 07710533 T AT07710533 T AT 07710533T AT 07710533 T AT07710533 T AT 07710533T AT E551067 T1 ATE551067 T1 AT E551067T1
Authority
AT
Austria
Prior art keywords
tumstatin
remodeling
treatment
diseases related
respiratory tissue
Prior art date
Application number
AT07710533T
Other languages
English (en)
Inventor
Sarah Boustany
Janette Burgess
Judith Black
Brian Oliver
Original Assignee
Crc For Asthma And Airways Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crc For Asthma And Airways Ltd filed Critical Crc For Asthma And Airways Ltd
Application granted granted Critical
Publication of ATE551067T1 publication Critical patent/ATE551067T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07710533T 2006-02-03 2007-02-02 Tumstatin zur behandlung von erkrankungen die mit der neumodellierung von atemwegsgewebe zusammenhängen ATE551067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76483306P 2006-02-03 2006-02-03
PCT/AU2007/000106 WO2007087689A1 (en) 2006-02-03 2007-02-02 A method of modulating cellular activity and agents for use therein

Publications (1)

Publication Number Publication Date
ATE551067T1 true ATE551067T1 (de) 2012-04-15

Family

ID=38327093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07710533T ATE551067T1 (de) 2006-02-03 2007-02-02 Tumstatin zur behandlung von erkrankungen die mit der neumodellierung von atemwegsgewebe zusammenhängen

Country Status (5)

Country Link
US (2) US8227419B2 (de)
EP (2) EP2468294A1 (de)
AT (1) ATE551067T1 (de)
AU (1) AU2007211846B2 (de)
WO (1) WO2007087689A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012529438A (ja) * 2009-06-09 2012-11-22 シーアールシー フォー アズマ アンド エアウェイズ リミテッド 治療方法
WO2012113785A1 (en) 2011-02-21 2012-08-30 Fibrostatin S.L. Methods for treating and diagnosing disease
ES2659161T3 (es) 2011-08-17 2018-03-14 The Regents Of The University Of Colorado, A Body Corporate Proteína de fusión de transferrina-tumstatina y métodos para producir y usar la misma
AU2016230009A1 (en) * 2015-03-06 2017-10-12 Georgia State University Research Foundation, Inc. Integrin-targeting protein and methods of use thereof
GB201721387D0 (en) * 2017-12-20 2018-01-31 Nordic Bioscience As Tumstatin assay

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4019653A (en) 1975-08-22 1977-04-26 Graco Inc. Automatic proportioning paint spray system
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5433896A (en) 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US5326692B1 (en) 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
US5723218A (en) 1990-04-16 1998-03-03 Molecular Probes, Inc. Dipyrrometheneboron difluoride labeled flourescent microparticles
US5274113A (en) 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5648270A (en) 1995-02-06 1997-07-15 Molecular Probes, Inc. Methods of sensing with fluorescent conjugates of metal-chelating nitrogen heterocycles
US5453517A (en) 1992-02-25 1995-09-26 Molecular Probes, Inc. Reactive derivatives of bapta used to make ion-selective chelators
US5405975A (en) 1993-03-29 1995-04-11 Molecular Probes, Inc. Fluorescent ion-selective diaryldiaza crown ether conjugates
US5227487A (en) 1990-04-16 1993-07-13 Molecular Probes, Inc. Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
US5459276A (en) 1994-05-20 1995-10-17 Molecular Probes, Inc. Benzazolylcoumarin-based ion indicators for heavy metals
US5770358A (en) 1991-09-18 1998-06-23 Affymax Technologies N.V. Tagged synthetic oligomer libraries
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US5753187A (en) 1996-06-14 1998-05-19 Stovall Life Science, Inc. Combinatorial chemistry cassette
US7387779B2 (en) * 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
WO2000059532A1 (en) * 1999-04-01 2000-10-12 Biostratum, Inc. The use of domains of type iv collagen t inhibit angiogenesis an tumour growth
CN1420926A (zh) * 2000-01-07 2003-05-28 贝丝以色列迪克尼斯医疗中心 抗生血管蛋白和片段及其应用方法
WO2005103281A2 (en) 2004-04-26 2005-11-03 Children's Medical Center Corporation Platelet biomarkers for the detection of disease
CA2583399A1 (en) 2004-10-14 2006-04-27 Sopherion Therapeutics, Inc. Anti-angiogenic peptides and methods of use thereof
WO2006128027A1 (en) * 2005-05-26 2006-11-30 Peptx, Inc. Functionally active recombinant peptides, methods for producing same and interactions with other peptides
EP2015781A4 (de) 2005-09-12 2009-12-23 Univ Johns Hopkins Zusammensetzungen mit antiangiogener wirkung und ihre verwendungen

Also Published As

Publication number Publication date
US20090221494A1 (en) 2009-09-03
EP1988915A4 (de) 2009-11-11
EP1988915B1 (de) 2012-03-28
AU2007211846B2 (en) 2013-05-23
US8227419B2 (en) 2012-07-24
WO2007087689A1 (en) 2007-08-09
AU2007211846A1 (en) 2007-08-09
EP1988915A1 (de) 2008-11-12
EP2468294A1 (de) 2012-06-27
US20120283192A1 (en) 2012-11-08

Similar Documents

Publication Publication Date Title
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
EA201001639A1 (ru) Композиции и способы их получения и применения
CY1113024T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου για τη θεραπεια της εξαρτησης ουσιων
EA201000914A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
ATE453642T1 (de) Substituierte phenylaminopyrimidine
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE447551T1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE602005017636D1 (de) Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen
IN2012DN04085A (de)
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
CY1116938T1 (el) Αναπληρωτικη θεραπεια της ασθενειας huntington και αλλων ασθενειων πολυγλουταμiνης
ATE551067T1 (de) Tumstatin zur behandlung von erkrankungen die mit der neumodellierung von atemwegsgewebe zusammenhängen
TN2009000503A1 (en) Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
ATE510536T1 (de) Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
NO20076405L (no) Anvendelse av 24-nor-UDCA
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
DE502006007982D1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
HRP20050786A2 (en) Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
ATE527997T1 (de) Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien
ATE479423T1 (de) Vorrichtung für die topische anwendung des medizinischen ozons zur behandlung von erkrankungen der mundhöhle
CY1115587T1 (el) Μεθοδος και συνθεση για την θεραπεια παθησης με την μεσολαβηση ενος ληπτη σεροτονινης (sεrοτονιν)